Abstract Scope |
The invention and use of antibiotics have significantly reduced infections and saved millions of lives. However, the extensive use of antibiotics has created new challenges in patient care, i.e., antibiotic resistant bacteria, which have been increasingly seen in recent decades. Besides antibiotic resistance, infection control and treatments are facing other challenges including intracellular infection, biofilm formation, delayed wound healing, etc. The recent COVID-19 have further reminded us of the challenges in dealing with infections. Biomaterials and nanotechnology have inspired excitements in controlling and treating infections and other diseases, and the most recent use of lipid nanoparticles in the Pfizer-BioNTech and Moderna COVID-19 vaccines was a great success. In this talk, the development of antimicrobial biomaterials and nanomedicine targeting intracellular infection will be presented. |